Ruixin Wang

Tianjin University of Science and Technology

Also affiliated with Fudan University, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer”.

Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-0874

N/A

0DataRank · unranked

27 citations

Yanquan Zhang, Fengyi Mao, Zhuangzhuang Zhang, Zhiguo Li, Ruixin Wang +3 more

Epigenetics in prostate cancer treatment

Journal of Translational Genetics and Genomics(2021)10.20517/jtgg.2021.19

N/A

0DataRank · unranked

17 citations

Yanquan Zhang, Yifan Kong, Elia Farah, Ruixin Wang, Chaohao Li +7 more

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer

Advanced Science(2021)10.1002/advs.202101458

N/A

0DataRank · unranked

17 citations

Lijun Cheng, Qiongsi Zhang, Yifan Kong, Daheng He, Kunyu Li +13 more

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer

Advanced Science(2022)10.1002/advs.202202572

N/A

0DataRank · unranked

2 citations

Lijun Cheng, Qiongsi Zhang, Yifan Kong, Daheng He, Kunyu Li +13 more

Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis

Cell Reports(2024)10.1016/j.celrep.2024.114431

N/A

0DataRank · unranked

15 citations

Ka-wing Fong, Fengyi Mao, Ruixin Wang, Derek B. Allison, Dana Napier +10 more